Intravesical recurrence after surgical management of urothelial carcinoma of the upper urinary tract

Urologia Internationalis

Volumn 89, Issue 1, 2012, Pages 71-77

  Hirano, Daisaku ^a   Okada, Yasuhiro ^a   Nagane, Yusuke ^a   Satoh, Katsuhiko ^a   Mochida, Junichi ^a   Yamanaka, Yataroh ^a   Hirakata, Hitoshi ^a   Yamaguchi, Kenya ^a   Kawata, Nozomu ^a   Takahashi, Satoru ^a   Henmi, Akihiro ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bladder cancer; Intravesical recurrence; Nephroureterectomy; Upper urinary tract; Urothelial carcinoma

Indexed keywords

AGED; ARTICLE; BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CYSTOSCOPY; CYTOLOGY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; NEPHROURETERECTOMY; OPERATION DURATION; PERIOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; TUMOR LOCALIZATION; TUMOR VOLUME;

CARCINOMA; CHI-SQUARE DISTRIBUTION; CYSTOSCOPY; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; LYMPHATIC METASTASIS; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; NEPHRECTOMY; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN; URETERAL NEOPLASMS; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 84864601867     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000338644     Document Type: Article

References (28)

1. Ploeg M, Aben KK, Kiemenery LA: The present and future burden of urinary bladder cancer in the world. World J Urol 2009; 27: 289-293.
2. Jema A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ: Cancer statistics 2009. CA Cancer J Clin 2009; 59: 225-249.
3. Walsh PC, Retik AB, Vaughan Jr ED, et al: Campbell's Urology, ed 9. Philadelphia, Saunders, 2007, p 1638.
4. Kirkali Z, Tuzel E: Transitional cell carcinoma of the ureter and renal pelvis. Crit Rev Oncol Hematol 2003; 47:155-169. (Pubitemid 36945314)
5. Hisakata T, Miyao N, Masumori N, Taka-hashi A, Sasai M, Yanase M, Itoh N, Tsuka-moto T: Risk factors for the development of bladder cancer after upper urinary tract uro-thelial cancer. Urology 2000; 55:663-667.
6. Kang CH, Yu TJ, Hsieh HH, Yang JW, Shu K, Huang CC, Chiang PH, Shiue YL: The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract. Cancer 2003; 98:1620-1626. (Pubitemid 37238617)
7. Mullerad M, Russo O, Golijanin D, Chen HN, Tsai HH, Donat SM, Bochner BH, Herr HW, Sheinfeld J, Sogani PC, Kattan MW, Dalbagni G: Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma. J Urol 2004; 172:2177-2181. (Pubitemid 39507486)
8. Matsui Y, Utsunomiya N, Ichioka K, Ueda N, Yoshimura K, Terai A, Arai Y: Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract. Urology 2005; 65: 279-283. (Pubitemid 40248013)
9. Raman JD, Ng CK, Boorjian SA, Vaughan Jr ED, Sosa RE, Scherr DS: Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology. BJU Int 2005; 96:1031-1035. (Pubitemid 41531409)
10. Zigeuner RE, Hutterer G, Chromecki T, Re-hak P, Langner C: Bladder tumor development after urothelial carcinoma of the upper urinary tract is related to primary tumour location. BJU Int 2006; 98:1181-1186. (Pubitemid 44721221)
11. Koda S, Mita K, Shigeta M, Usui T: Risk factors for intravesical recurrence following urothelial carcinoma of the upper urinary tract: no relationship to the mode of surger y. Jpn J Clin Oncol 2007; 37: 296-301. (Pubitemid 47090682)
12. Chung SD, Huang KH, Lai MK, Huang CY, Chen CH, Pu YS, Yu HJ, Chueh SC: CKD as a risk factor for bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma. Am J Kidney Dis 2007; 50:743-753.
13. Terakawa T, Miyake H, Muramaki M, Takenaka A, Hara I, Fujisawa M: Risk factors for intravesical recurrence after surgical management of the upper urinary tract. Urology 2008; 71: 123-127. (Pubitemid 351173269)
14. Li CC, Chang TH, Wu WJ, Ke HL, Huang SP, Tsai PC, Chang SJ, Chen JT, Chou YH, Huang CH: Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients. Eur Urol 2008; 54:1127-1134.
15. Huang WW, Huang HY, Liao AC, Shiue YL, Tai HL, Lin CM, Wang YH, Lin CN, Shen KH, Li CF: Primary urothelial carcinoma of the upper tract: important clinicopathologi-cal factors predicting bladder recurrence after surgical resection. Pathol Int 2009; 59: 642-649.
16. Ku JH, Choi WS, Kwak C, Kim HH: Bladder cancer after nephroureterectomy in patients with urothelial carcinoma of the upper urinary tract. Urol Oncol 2011; 29:383-387.
17. Milojevic B, Djokic M, Sipetic-Grujicic S, Milenkovic-Petronic D, Vuksanovic A, Dragicevic D, Bumbasirevic U, Tulic C: Bladder cancer after managing upper urinary tract transitional cell carcinoma: risk factors and survival. Int Urol Nephrol 2011; 43:729-735.
18. Sobin LH, Witterkind C (eds): TNM Classification of Malignant Tumors, ed 6. New York, Wiley-Liss, 2002.
19. Lopez-Beltran A, Sauter G, Gasser T, et al: Tumor of the urinary system. Infiltrating urothelial carcinoma; in Eble JN, Sauter G, Epstein JI Sesterhenn IA (eds): World Health Organization Classification of Tumors. Pathology and Genetics. Tumors of the Urinary System and Male Genital Organs. Lyon, IARC Press, 2004, pp 93-109.
20. Hafner C, Knuechel R, Stoehr R, Hartmann A: Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies. Int J Cancer 2002; 101:1-6. (Pubitemid 34832989)
21. Takahashi T, Habuchi T, Kakehi Y, Mitsu-mori K, Akao T, Terachi T, Yoshida O: Clon-al and chronological genetic analysis of mul-tifocal cancer of the bladder and upper uri-nar y tract. Cancer Res 1998; 58: 5835-5841. (Pubitemid 29006426)
22. Habuchi T, Takahashi R, Yamada H, Kakehi Y, Sugiyama T, Yoshida O: Metachronous multiple development of urothelial cancers by intraluminal seeding. Lancet 1993; 342: 1087-1088. (Pubitemid 23338743)
23. Kakizoe T, Fujita J, Murase T, Matsumoto K, Kishi K: Transitional cell carcinoma of the bladder in patients with renal pelvic and ure-teral cancer. J Urol 1980; 124:17-9. (Pubitemid 10032422)
24. Akdogan B, Dogan HS, Eskicorapci SY, Sa-hin A, Erkan I, Ozen H: Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma. J Urol 2006; 176: 48-52. (Pubitemid 43815384)
25. Sylvester RJ, Oosterlinck W, van der Meijden AP: A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta analysis of published results of randomized clinical trials. J Urol 2004; 171:2186-2190. (Pubitemid 38625431)
26. Babjuk M, Oosterlinck W, Sylvester R, Kaa-sinen E, Bohle A, Palou-Redorta J, Roupret M, European Association of Urology: EAU guidelines on non-muscle-invasive urothe-lial carcinoma of the bladder, the 2011 update. Eur Urol 2011; 59: 997-1008.
27. O'Brien T, Ray E, Singh R, Coker B, Beard R: Prevention of bladder tumours after nephro-ureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomized clinical trial of a single postoperative intravesical dose of mi-tomycin C (the ODMIT-C Trial). Eur Urol 2001; 60:703-710.
28. Soga N, Arima K, Sugimura Y: Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma. Int J Urol 2008; 15: 800-803.